These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 15578371

  • 21. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F, Thiébaut R, Chêne G, Neau D, Pellegrin JL, Mercié P, Beylot J, Dabis F, Salamon R, Morlat P, Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA).
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [Abstract] [Full Text] [Related]

  • 22. [Change in the survival of Cuban AIDS patients with tuberculosis in the Highly Active Antiretroviral Therapy (HAART) era].
    Reyes-Corcho A, Capo de Paz V, Díaz-Jidy M, Pérez-Avila J, Bouza-Jiménez Y.
    Invest Clin; 2008 Sep; 49(3):309-20. PubMed ID: 18846772
    [Abstract] [Full Text] [Related]

  • 23. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC, Wong KH, Lee SS.
    HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
    [Abstract] [Full Text] [Related]

  • 24. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B.
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [Abstract] [Full Text] [Related]

  • 25. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.
    J Infect Dis; 2007 Oct 01; 196(7):1044-52. PubMed ID: 17763327
    [Abstract] [Full Text] [Related]

  • 26. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
    Arendt G.
    Fortschr Neurol Psychiatr; 2005 Oct 01; 73(10):577-86. PubMed ID: 16217698
    [Abstract] [Full Text] [Related]

  • 27. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct 01; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 28. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH.
    Clin Infect Dis; 2007 Feb 15; 44(4):584-90. PubMed ID: 17243064
    [Abstract] [Full Text] [Related]

  • 29. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK.
    J Infect Dis; 2002 Oct 01; 186(7):1023-7. PubMed ID: 12232845
    [Abstract] [Full Text] [Related]

  • 30. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A, Burgess P, Judd F, Grech P, Komiti A, Hoy J, Lloyd JH, Gibbie T, Street A.
    HIV Med; 2006 May 01; 7(4):205-12. PubMed ID: 16630032
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May 01; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 32. Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma.
    Bower M, Powles T, Nelson M, Mandalia S, Gazzard B, Stebbing J.
    J Natl Cancer Inst; 2006 Aug 02; 98(15):1088-91. PubMed ID: 16882946
    [Abstract] [Full Text] [Related]

  • 33. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM.
    J Clin Oncol; 2005 Feb 20; 23(6):1253-60. PubMed ID: 15718323
    [Abstract] [Full Text] [Related]

  • 34. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Nasti G, Martellotta F, Berretta M, Mena M, Fasan M, Di Perri G, Talamini R, Pagano G, Montroni M, Cinelli R, Vaccher E, D'Arminio Monforte A, Tirelli U, GICAT, ICONA.
    Cancer; 2003 Dec 01; 98(11):2440-6. PubMed ID: 14635079
    [Abstract] [Full Text] [Related]

  • 35. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 36. Toxoplasmic encephalitis and primary lymphoma of the brain--the shift in epidemiology: a case series and review of the literature.
    Olatinwo TF, Herbowy MT, Hewitt RG.
    AIDS Read; 2001 Sep 15; 11(9):444-9. PubMed ID: 11682917
    [Abstract] [Full Text] [Related]

  • 37. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
    Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS.
    Arch Intern Med; 2005 May 23; 165(10):1179-84. PubMed ID: 15911733
    [Abstract] [Full Text] [Related]

  • 38. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy.
    Diamond C, Taylor TH, Im T, Miradi M, Anton-Culver H.
    Hematol Oncol; 2006 Sep 23; 24(3):139-45. PubMed ID: 16604565
    [Abstract] [Full Text] [Related]

  • 39. Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy.
    Gervasoni C, Ridolfo AL, Vaccarezza M, Parravicini C, Vago L, Adorni F, Cappelletti A, d'Arminio Monforte A, Galli M.
    Clin Infect Dis; 2002 Dec 15; 35(12):1534-40. PubMed ID: 12471574
    [Abstract] [Full Text] [Related]

  • 40. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F, Spanish Pneumococcal Infection Study Network (G03/103).
    Arch Intern Med; 2005 Jul 11; 165(13):1533-40. PubMed ID: 16009870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.